Key facts
- What SIBO is: excess bacteria in the small intestine (IMO is the methane form).
- How it's diagnosed: breath testing (hydrogen/methane) — not stool.
- GI-MAP's role: a large-intestine stool profile; it does NOT diagnose SIBO.
- Where it can help: flags methanogens and dysbiosis patterns some practitioners weigh alongside breath testing.
Small intestinal bacterial overgrowth (SIBO) — and its methane-predominant form, intestinal methanogen overgrowth (IMO) — involves excess microbes in the small intestine. An important point up front: SIBO and IMO are diagnosed with breath testing, not stool testing. The GI-MAP (Gastrointestinal Microbial Assay Plus) is a stool test and does not diagnose SIBO.
Why a stool test is not a SIBO test
SIBO is fundamentally about where microbes are — too many in the small intestine. A stool sample reflects the large intestine, so it cannot confirm small-bowel overgrowth. That is why the standard tests for SIBO and IMO are hydrogen and methane breath tests, and why the GI-MAP should not be used as a substitute for them.
What the GI-MAP can still add
The GI-MAP does detect methanogenic archaea (Methanobacteriaceae) and can show broader dysbiosis patterns — shifts in the balance of gut bacteria that are studied as a general marker of gut imbalance (PMID: 32438689). Some practitioners review these findings alongside a breath test to build a fuller picture of the gut. On their own, they are context, not a SIBO diagnosis.
If SIBO or IMO is suspected, the right next step is to discuss breath testing with a qualified practitioner.
The GI-MAP™ reports this and 85+ other markers from one at-home sample.
Order Your GI-MAP™ Test → See pricingReferences
- Magne F, Gotteland M, Gauthier L, et al. The Firmicutes/Bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients? Nutrients. 2020;12(5):1474. PMID: 32438689.